A study appearing in the Annals of Internal Medicine documents over 100 deaths during US triathlons over the past 20 years. What common factors underlie that risk? For the video version, click here.
Read MoreA study appearing in JAMA Internal Medicine links the cost of developing a new drug to the ultimate revenue a company receives. The results suggest that curbing R&D costs may not have much effect on drug pricing at all. For the video version, click here.
Read MoreA randomized trial appearing in JAMA Internal Medicine reveals modest, but significant effects of transdermal estrogen on sexual function in post-menopausal women. But there are some caveats. For the video version, click here.
Read MoreA research letter appearing in JAMA Internal Medicine documents a striking decrease in work hours among women physicians once they have children - a finding that does not extend to their male physician spouses. For the video version, click here.
Read MoreMedical devices are regulated by the FDA in a similar way to drugs, but a recent study appearing in JAMA suggests that the approval process may be too lax. For the video version, click here.
Read MoreA study appearing in the Journal of the American Medical Association found that improvisational music therapy did not improve outcomes in kids with autism. But was it the intervention that didn't work, or the trial itself? For the video version, click here.
Read MoreMaintenance of Certification is the process by which docs prove they've kept up with the times in terms of medical knowledge. That's all well and good, but the sky-high exam fees beg the question - where does the money go? For the video version, click here.
Read MoreAn autopsy study reveals that 99% of the brains of NFL players had evidence of chronic traumatic encephalopathy. Will this condition be the end of football? For the video version, click here.
Read MoreThe Hospital Readmission Reduction Program, which lowered Medicare payments to hospitals with high readmission rates, has accomplished its direct goal of reducing readmission rates. This study, appearing in JAMA, evaluates for potential unintended consequences. For the video version, click here.
Read MoreA study appearing in the Journal of the American Medical Association examined whether the addition of bupropion or the antipsychotic aripiprazole to first-line antidepressant therapy would improve outcomes in major depressive disorder. The results highlight how difficult this disease is to treat. For the video version, click here.
Read More
